MindMed Acquires HealthMode
MindMed (OTCQB: MMEDF), a New York City-based biotechnology company, is expanding its platform with a new deal. Last week, the company announced it is acquiring HealthMode, a digital medicine and therapeutics startup that uses artificial intelligence-enabled digital measurement to increase the precision and speed of clinical research and patient monitoring. MindMed will issue 8,250,836 subordinate voting shares at the Feb. 17, 2021 closing price of CAD 5.13, plus approx. CAD 300,000 in cash. Based on the conversion rate from February 18, 2021, the price comes out to approximately U.S. $33.67 million. The acquisition of Healthmode is expected to close by the end of February 2021. MindMed is... Read More »
Sharecare Is Going Public
Last week Sharecare, Inc. announced it was going public in a reverse merger with Falcon Capital Acquisition Corp. (NASDAQ: FCAC), a special purpose acquisition company (SPAC). Sharecare provides an online health and wellness engagement platform that gives consumers a personal results-oriented experience by connecting them to health resources and programs. Falcon Capital is in an investment partnership with Eagle Equity Partners. The deal is valued at $3.9 billion and is expected to be funded through a combination of Falcon’s $345 million of cash in trust supported by a $425 million PIPE at $10.00 per share. Sharecare will have approximately $400 million on its balance sheet to fund growth... Read More »
MultiPlan Corporation Acquires Discovery Health Partners
MultiPlan Corporation (NYSE: MPLN), a leading value-add provider of data analytics and technology-enabled end-to-end cost management solutions to the U.S. healthcare industry, is wasting no time in expanding. If the name rings a bell, it’s because MultiPlan just went public in July 2020 in an $11 billion reverse merger with Churchill Capital Corp III, a special purpose acquisition company (SPAC). It was one of the biggest deals of 2020, and one of many in healthcare involving a reverse merger with a SPAC. Since MultiPlan went public, the company has announced two transactions under its “Enhance-Extend-Expand strategy,” including the most recent one for Discovery Health Partners, valued at... Read More »
Hill-Rom Holdings Hits the Ground Running
Only a month into the new year and Hill-Rom Holdings, Inc. (NYSE: HRC) already has two acquisitions on the books, according to search results in our Healthcare Deal Database. Hill-Rom Holdings operates as a medical technology company worldwide. Its products enable earlier diagnosis and treatment, optimize surgical efficiency and accelerate patient recovery while simplifying clinical communication and shifting care closer to home. Back on January 19, the medical device company acquired Bardy Diagnostics, Inc. for $375 million in cash, plus net operating losses valued at more than $20 million. Bardy Diagnostics was founded in 2013 and helps improve clinical management and outcomes for... Read More »
Talkspace Goes Public in Another Reverse Merger
In 2020, reverse mergers with special purpose acquisition companies (SPACs) popped up on a weekly basis, and it seems like that trend is spilling over into 2021. This week, Talkspace, a tele-behavioral healthcare company, announced it is going public after it merges with Hudson Executive Investment Corp. (NASDAQ: HEC), a SPAC formed by Hudson Executive Capital LP (HEC), Douglas L. Braunstein and Douglas G. Bergeron. Mr. Braunstein is the founder and co-managing partner of HEC and the former CFO and Vice Chairman of JP Morgan. Mr. Bergeron is a co-managing partner of HEC and the former Chairman and CEO of VeriFone, Inc. The deal is valued at an initial enterprise value of $1.4 billion, plus... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
